Abstract
Recombinant proteins have various applications in basic and applied research, as well as in therapy. Numerous systems have been developed to produce large protein amounts (1–3). The most convenient systems are those that involve the overexpression of recombinant proteins in bacteria, mainly because they are fast and easy. However, there is a need for eukaryotic overexpression systems, because several proteins require either the proper folding environment or posttranslational modifications for physiological activity (4). The ideal system for eukaryotic overexpression would have integration of the expression cassette in the genome of the target cell at a location that permits strong and long-term expression. However, most current methods for achieving integration of plasmid DNA into the genome involve random integration of DNA (5–8). Expression of the recombinant protein in clones generated by such methods is dependent on the chromatin context at the site of integration and often leads to low expression levels (9,10). Therefore, many clones should be screened to find those expressing the protein of interest at the desired level.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Roy, P. and Jones, I. (1996) Assembly of macromolecular complexes in bacterial and baculovirus expression systems. Curr. Opin. Struct. Biol. 6, 157–161.
Makrides, S. C. (1996) Strategies for achieving high-level expression of genes in Escherichia coli. Microbiol. Rev. 60, 512–538.
Geisse, S., Gram, H., Kleuser, B., and Kocher, H. P. (1996) Eukaryotic expression systems: a comparison. Protein Expr. Purif. 8, 271–282.
Weikert, S., Papac, D., Briggs, J., Cowfer, D., Tom, S., Gawlitzek, M., et al. (1999) Engineering Chinese hamster ovary cells to maximize sialic acid content of recombinant glycoproteins. Nat. Biotechnol. 17, 1116–1121.
Kaufman, R. J., Davies, M. V., Wasley, L. C., and Michnick, D. (1991) Improved vectors for stable expression of foreign genes in mammalian cells by use of the untranslated leader sequence from EMC virus. Nucleic Acids Res. 19, 4485–4490.
Kaufman, R. J. (2000) Overview of vector design for mammalian gene expression. Mol. Biotechnol. 16, 151–160.
Lucas, B. K., Giere, L. M., DeMarco, R. A., Shen, A., Chisholm, V., and Crowley, C. W. (1996) High-level production of recombinant proteins in CHO cells using a dicistronic DHFR intron expression vector. Nucleic Acids Res. 24, 1774–1779.
Cockett, M. I., Bebbington, C. R., and Yarranton, G. T. (1990) High level expression of tissue inhibitor of metalloproteinases in Chinese hamster ovary cells using glutamine synthetase gene amplification. Biotechnology (NY) 8, 662–667.
Kalos, M. and Fournier, R. E. (1995) Position-independent transgene expression mediated by boundary elements from the apolipoprotein B chromatin domain. Mol. Cell Biol. 15, 198–207.
Zahn-Zabal, M., Kobr, M., Girod, P. A., Imhof, M., Chatellard, P., de Jesus, M., et al. (2001) Development of stable cell lines for production or regulated expression using matrix attachment regions. J. Biotechnol. 87, 29–42.
Groth, A. C., Olivares, E. C., Thyagarajan, B., and Calos, M. P. (2000) A phage integrase directs efficient site-specific integration in human cells. Proc. Natl. Acad. Sci. USA 97, 5995–6000.
Thyagarajan, B., Olivares, E. C., Hollis, R. P., Ginsburg, D. S., and Calos, M. P. (2001) Site-specific genomic integration in mammalian cells mediated by phage phiC31 integrase. Mol. Cell Biol. 21, 3926–3934.
Olivares, E. C., Hollis, R. P., Chalberg, T. W., Meuse, L., Kay, M. A., and Calos, M. P. (2002) Site-specific genomic integration produces therapeutic Factor IX levels in mice. Nat. Biotechnol. 20, 1124–1128.
Ortiz-Urda, S., Thyagarajan, B., Keene, D. R., Lin, Q., Fang, M., Calos, M. P., and Khavari, P. A. (2002) Stable nonviral genetic correction of inherited human skin disease. Nat. Med. 8, 1166–1170.
Ortiz-Urda, S., Thyagarajan, B., Keene, D. R., Lin, Q., Calos, M. P., and Khavari, P. A. (2003) PhiC31 integrase-mediated nonviral genetic correction of junctional epidermolysis bullosa. Hum. Gene Ther. 14, 923–928.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc.
About this protocol
Cite this protocol
Thyagarajan, B., Calos, M.P. (2005). Site-Specific Integration for High-Level Protein Production in Mammalian Cells. In: Smales, C.M., James, D.C. (eds) Therapeutic Proteins. Methods in Molecular Biology™, vol 308. Humana Press. https://doi.org/10.1385/1-59259-922-2:099
Download citation
DOI: https://doi.org/10.1385/1-59259-922-2:099
Publisher Name: Humana Press
Print ISBN: 978-1-58829-390-9
Online ISBN: 978-1-59259-922-6
eBook Packages: Springer Protocols